Internal Medicine, Pulmonary Disease · Boston, MA
NPI
1336167857
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
Mass General Hospital, 55 Fruit St, Bulf 148
Boston, MA, 02114
Phone (617) 726-1721
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,326 services
Medicare patients, 2024
480
Average age 76
Drug cost, 2024
$1.9M
2,803 prescriptions
Company payments, 2025
$117
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David L Miller was code 99214 (office e&m - established), 525 times for 333 patients. In total David L Miller billed 1,326 services in 32 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 525 | 333 | $105.17 | $55K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 213 | 179 | $13.76 | $2,930 |
| 99215 Office E&M - Established | Office | 159 | 114 | $153.05 | $24K |
| 99205 Office E&M - New | Office | 72 | 72 | $180.04 | $13K |
| 99213 Office E&M - Established | Office | 62 | 57 | $64.92 | $4,025 |
| 99233 Hospital E&M - Subsequent | Facility | 60 | 25 | $98.48 | $5,909 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 39 | 37 | $29.46 | $1,149 |
| 99406 Behavioral Health Services | Office | 35 | 26 | $15.74 | $551 |
| 99223 Hospital E&M - Initial | Facility | 29 | 28 | $143.78 | $4,170 |
| 99204 Office E&M - New | Office | 26 | 26 | $142.25 | $3,698 |
| G0008 Administration of influenza virus vaccine | Office | 19 | 19 | $35.30 | $671 |
| 90662 Vaccine Product | Office | 18 | 18 | $81.27 | $1,463 |
| G0009 Administration of pneumococcal vaccine | Office | 11 | 11 | $35.30 | $388 |
| 90677 Vaccine Product | Office | 11 | 11 | $289.57 | $3,185 |
By year: 2022 $86K for 854 services; 2023 $98K for 945 services; 2024 $123K for 1,326 services.
Medicare prescription drug claims, 2024
In 2024, the drug David L Miller prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 492 prescriptions and refills. In total David L Miller wrote 2,803 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 492 | 632 | 104 | $393K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 311 | 356 | 109 | $9,424 |
| Montelukast Sodium Generic | 158 | 389 | 47 | $3,004 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 149 | 201 | 38 | $122K |
| Prednisone Generic | 134 | 179 | 63 | $1,035 |
| Breo Ellipta Fluticasone/Vilanterol | 123 | 165 | 26 | $63K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 115 | 137 | 29 | $13K |
| Azithromycin Generic | 100 | 124 | 41 | $1,250 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 86 | 128 | 24 | $56K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 60 | 83 | 16 | $9,549 |
| Eliquis Apixaban | 56 | 76 | Under 11 | $41K |
| Incruse Ellipta Umeclidinium Bromide | 55 | 75 | 16 | $26K |
| Ventolin Hfa Albuterol Sulfate | 51 | 63 | 16 | $4,650 |
| Spiriva Respimat Tiotropium Bromide | 49 | 77 | 13 | $38K |
| Arnuity Ellipta Fluticasone Furoate | 49 | 67 | 16 | $15K |
Brand drugs: 1,734 claims; generic drugs: 1,069 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David L Miller $117 ($117 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Research & Development, LLC with $117.
| Company | Payments | Amount |
|---|---|---|
| Janssen Research & Development, LLC JNJ | 1 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.